As generative AI sweeps across industries, from healthcare to marketing to national defense, one major problem threatens to stall progress: infrastructure. The computer power required to support artificial intelligence is exponentially higher than traditional internet…
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic milestones. President and CEO Dr. Christopher J. Schaber highlighted upcoming…
Safe Pro Group (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI,…
HeartBeam (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. “HeartBeam’s vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical…
Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition to the Russell Microcap(R) Index, effective after market close on June 27, 2025. The inclusion comes as…
BluSky AI (OTC: BSAI), a developer of modular AI data center infrastructure, announced the acquisition of its first operational site in Central, Utah, securing 9.3 MW of grid-connected power through an agreement with Digital Asset…
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen…
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple…
BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable…
The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe pain, their high abuse potential has led to…
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
Newton Golf Company (NASDAQ: NWTG) is positioned for opportunity as it brings innovation to golf players seeking performance gains. The company recently launched its latest product: the Fast Motion shaft family, aiming to redefine performance standards…
As the private credit market continues to evolve, FAVO Capital (OTC: FAVO) is positioned to capitalize on emerging opportunities. “FAVO stands out as a leading private credit provider, specializing in delivering fast, efficient and personalized funding solutions…
Solowin Holdings (NASDAQ: SWIN) is focused on delivering comprehensive investment solutions from traditional finance as well as decentralized finance to high-net-worth and institutional clients. “Operating through its wholly owned subsidiary, Solomon JFZ (Asia) Holdings Limited, Solowin…
In a recent webinar hosted by Allele Capital, Soligenix (NASDAQ: SNGX) executives Dr. Christopher Schaber and Dr. Christopher Pullion shared detailed updates on the company’s HyBryte(TM) (synthetic hypericin) clinical development (https://ibn.fm/dz7eO). The event offered an in-depth look…